LYNCH RYAN (See Remarks) sold 3.2% of their position (465.00 shares) of CRESCENT BIOPHARMA, INC. on the open market
Open‑market sale worth $8.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/23/2026ACC: 0001628280-26-044893
Officer· See Remarks
Since Jun 2025
-465.00
Net shares
Net seller
$8.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
465.00 disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−465.00
Price / share
$17.99
Trade value
$8.37K
% of position
3.2%
6/22/2026
14.34K→13.87K
Total
Net shares
−465.00
Net value
-$8.37K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 6/22/2026 | S · Sale | −465.00 | $17.99 | $8.37K | 3.2% | 14.34K | 13.87K |
| Total | −465.00 | -$8.37K | ||||||
Derivative Transactions0
No derivative transactions reported